C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 1 filers reported holding C4 THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,888 | -32.4% | 2,628 | 0.0% | 0.00% | – |
| Q2 2023 | $7,227 | -12.4% | 2,628 | 0.0% | 0.00% | – |
| Q1 2023 | $8,252 | -46.8% | 2,628 | 0.0% | 0.00% | – |
| Q4 2022 | $15,505 | -32.6% | 2,628 | 0.0% | 0.00% | – |
| Q3 2022 | $23,000 | +15.0% | 2,628 | 0.0% | 0.00% | – |
| Q2 2022 | $20,000 | -94.3% | 2,628 | -81.9% | 0.00% | -100.0% |
| Q1 2022 | $353,000 | +70.5% | 14,540 | +126.5% | 0.00% | – |
| Q4 2021 | $207,000 | -60.3% | 6,420 | -45.0% | 0.00% | -100.0% |
| Q3 2021 | $522,000 | – | 11,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $17,795,000 | 7.09% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $60,745,000 | 3.44% |
| Soleus Capital Management, L.P. | 464,068 | $17,166,000 | 3.09% |
| Cormorant Asset Management, LP | 2,490,065 | $92,107,000 | 2.05% |
| P.A.W. CAPITAL CORP | 50,000 | $1,850,000 | 1.63% |
| Perceptive Advisors | 3,158,566 | $116,835,000 | 1.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 497,136 | $18,389,000 | 1.41% |
| Mizuho Securities Co. Ltd. | 169,392 | $6,266,000 | 1.30% |
| RTW INVESTMENTS, LP | 2,149,228 | $79,437,000 | 1.24% |
| Darwin Global Management, Ltd. | 140,034 | $5,180,000 | 1.01% |